Fatih Gulsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fatih Gulsen has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
Fatih Kantarci
Department of Radiology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey
11 shared publicationsFuruzan Numan
Istanbul University-Cerrahpasa, Cerrahpasa School of Medicine, Department of Interventional Radiology, Fatih, Istanbul, Turkey
10 shared publicationsIsmail Mihmanli
Department of Radiology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
6 shared publications- Ibrahim Adaletli
Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Radiology, Istanbul, Türkiye
5 shared publications Murat Cantasdemir
Department of Radiology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey
5 shared publications- Ahmet Baş
Radiology Department, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul 34854, Turkey
4 shared publications
Latest Publications
- Open Access
Management and Clinical Outcomes of Liver Hemangiomas: A Retrospective Comparative Study of Transcatheter Arterial Embolization and Surgery
Background and Objectives: Hemangiomas are the most common benign tumors of the liver. Surgical options such as enucleation, segmentectomy, and hepatectomy are the primary treatment choices, though the morbidity and complication rates remain high. Transcatheter arterial embolization (TAE) has emerged as a safe and effective alternative treatment option that has gained popularity in recent years. Materials and Methods: We retrospectively evaluated data from patients who underwent either surgical intervention (n = 19) or transarterial embolization (62 lesions in 61 patients; analyses performed per treated lesion) for liver hemangioma between 2003 and 2021. Outcomes were assessed separately for each modality without a composite efficacy endpoint: clinical success (relief of the presenting symptoms, assessed in patients symptomatic at baseline), technical success and radiological response for embolization, treatment-related complications, length of hospital stay, and the need for reintervention. Results: There was no significant difference in the pretreatment size of the lesions between the TAE and surgery groups (median of 10.0 [IQR 7.8–13.9] versus 10.0 [IQR 9.0–17.0] cm; p = 0.100). The length of hospital stay was shorter in the TAE group (median of 1 versus 6 days; p < 0.001), although era-related differences in perioperative care may contribute to this difference, and follow-up was longer in surgically treated patients, reflecting the later adoption of embolization at our institution. Postoperative mortality did not occur in either group. In the embolization group, there were significant reductions in lesion size and volume and the complication rate was low, with no serious complications, supporting the safety profile of TAE. Conclusions: In this retrospective, non-randomized, single-center series, transarterial embolization was found to be a safe and effective minimally invasive treatment for liver hemangiomas and was associated with a shorter hospital stay. Because treatment allocation was not randomized, we cannot establish therapeutic equivalence between the two modalities, and the comparison should be regarded as descriptive; TAE represents an effective minimally invasive treatment option in appropriately selected patients and may be considered within a multidisciplinary treatment strategy, while surgery remains necessary in selected cases such as embolization failure, complicated lesion vascularization, or localization.
Open AccessManagement and Clinical Outcomes of Liver Hemangiomas: A Retrospective Comparative Study of Transcatheter Arterial Embolization and Surgery
Background and Objectives: Hemangiomas are the most common benign tumors of the liver. Surgical options such as enucleation, segmentectomy, and hepatectomy are the primary treatment choices, though the morbidity and complication rates remain high. Transcatheter arterial embolization (TAE) has emerged as a safe and effective alternative treatment option that has gained popularity in recent years. Materials and Methods: We retrospectively evaluated data from patients who underwent either surgical intervention (n = 19) or transarterial embolization (62 lesions in 61 patients; analyses performed per treated lesion) for liver hemangioma between 2003 and 2021. Outcomes were assessed separately for each modality without a composite efficacy endpoint: clinical success (relief of the presenting symptoms, assessed in patients symptomatic at baseline), technical success and radiological response for embolization, treatment-related complications, length of hospital stay, and the need for reintervention. Results: There was no significant difference in the pretreatment size of the lesions between the TAE and surgery groups (median of 10.0 [IQR 7.8–13.9] versus 10.0 [IQR 9.0–17.0] cm; p = 0.100). The length of hospital stay was shorter in the TAE group (median of 1 versus 6 days; p < 0.001), although era-related differences in perioperative care may contribute to this difference, and follow-up was longer in surgically treated patients, reflecting the later adoption of embolization at our institution. Postoperative mortality did not occur in either group. In the embolization group, there were significant reductions in lesion size and volume and the complication rate was low, with no serious complications, supporting the safety profile of TAE. Conclusions: In this retrospective, non-randomized, single-center series, transarterial embolization was found to be a safe and effective minimally invasive treatment for liver hemangiomas and was associated with a shorter hospital stay. Because treatment allocation was not randomized, we cannot establish therapeutic equivalence between the two modalities, and the comparison should be regarded as descriptive; TAE represents an effective minimally invasive treatment option in appropriately selected patients and may be considered within a multidisciplinary treatment strategy, while surgery remains necessary in selected cases such as embolization failure, complicated lesion vascularization, or localization.
- Open Access
- 14 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3776
Beyond Aesthetics: Imaging-Based Evaluation of Carboxytherapy in Periorbital Hyperpigmentation
Background: In this study, we radiologically assessed potential increases in microvascularity, extracellular matrix-related changes, and tissue viscoelasticity following carboxytherapy for periorbital hyperpigmentation (POH). We also analyzed the correlation between radiological changes and clinical outcomes and explored implications for future outpatient selection, as well as the potential to predict treatment success based on radiological–clinical correlations. Materials and Methods: The present study included 78 patients (76 women and 2 men) aged over 18 years with Fitzpatrick skin types I–V and moderate-to-severe infraorbital dark circles who applied for treatment at the Dermatology Department in the Cosmetology Unit of Cerrahpaşa Medical Faculty Hospital. Each patient was given manual, pressure-controlled injections of sterile CO2 into the upper and lower eyelids for 7 weeks, with one round of treatment per week. We conducted dermatoclinical and radiological evaluations, including measurements of epidermis–dermis thickness and SWE, musculus orbicularis oculi pars pretarsalis thickness, and cSMI vascular index percentage, as well as SOOF tissue SWE (measured in kPa). These analyses were performed on both lower eyelids before treatment and at 1 month and 6 months after treatment. Results: After treatment, VAS scores improved significantly. Grayscale ultrasonography showed significant increases in epidermis–dermis and orbicularis oculi thickness at 1 and 6 months (p < 0.05). SMI presented a significant increase in vascular index at both follow-ups (p < 0.05). SOOF SWE values increased significantly at 1 and 6 months, whereas epidermis–dermis SWE did not. Procedural pain was common, and 25 participants withdrew during the 7-week period due to discomfort. Injection depth was not confirmed by real-time imaging, and adverse events were not graded using a standardized classification system. Therefore, tolerability and procedural safety should be interpreted with caution. Conclusions: Carboxytherapy was associated with improvements in clinical outcomes and radiological parameters among patients who were able to tolerate the procedure, including increased microvascularity on SMI and changes suggestive of extracellular matrix-related alterations. These improvements were maintained at the 6-month follow-up, indicating temporal persistence of the observed findings. However, due to the absence of a control group, the results should be interpreted with caution, and further randomized controlled studies are required to confirm these findings and establish causality.
- 14 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3776
Open AccessBeyond Aesthetics: Imaging-Based Evaluation of Carboxytherapy in Periorbital Hyperpigmentation
Background: In this study, we radiologically assessed potential increases in microvascularity, extracellular matrix-related changes, and tissue viscoelasticity following carboxytherapy for periorbital hyperpigmentation (POH). We also analyzed the correlation between radiological changes and clinical outcomes and explored implications for future outpatient selection, as well as the potential to predict treatment success based on radiological–clinical correlations. Materials and Methods: The present study included 78 patients (76 women and 2 men) aged over 18 years with Fitzpatrick skin types I–V and moderate-to-severe infraorbital dark circles who applied for treatment at the Dermatology Department in the Cosmetology Unit of Cerrahpaşa Medical Faculty Hospital. Each patient was given manual, pressure-controlled injections of sterile CO2 into the upper and lower eyelids for 7 weeks, with one round of treatment per week. We conducted dermatoclinical and radiological evaluations, including measurements of epidermis–dermis thickness and SWE, musculus orbicularis oculi pars pretarsalis thickness, and cSMI vascular index percentage, as well as SOOF tissue SWE (measured in kPa). These analyses were performed on both lower eyelids before treatment and at 1 month and 6 months after treatment. Results: After treatment, VAS scores improved significantly. Grayscale ultrasonography showed significant increases in epidermis–dermis and orbicularis oculi thickness at 1 and 6 months (p < 0.05). SMI presented a significant increase in vascular index at both follow-ups (p < 0.05). SOOF SWE values increased significantly at 1 and 6 months, whereas epidermis–dermis SWE did not. Procedural pain was common, and 25 participants withdrew during the 7-week period due to discomfort. Injection depth was not confirmed by real-time imaging, and adverse events were not graded using a standardized classification system. Therefore, tolerability and procedural safety should be interpreted with caution. Conclusions: Carboxytherapy was associated with improvements in clinical outcomes and radiological parameters among patients who were able to tolerate the procedure, including increased microvascularity on SMI and changes suggestive of extracellular matrix-related alterations. These improvements were maintained at the 6-month follow-up, indicating temporal persistence of the observed findings. However, due to the absence of a control group, the results should be interpreted with caution, and further randomized controlled studies are required to confirm these findings and establish causality.
- Open Access
- 17 April 2026
- Published by MDPI AG in Preprints.org
Beyond Aesthetics: Imaging-Based Evaluation of Carboxytherapy in Periorbital Hyperpigmentation
Background: In this study, we radiologically assessed potential increases in microvascularity, the extracellular matrix, collagen deposition, and tissue viscoelasticity following carboxytherapy for periorbital hyperpigmentation (POH). We also analyzed the correlation between radiological changes and clinical outcomes and explored implications for future outpatient selection, as well as the potential to predict treatment success based on radiological–clinical correlations. Materials and Methods: The present study included 78 patients (76 women and 2 men) aged over 18 years with Fitzpatrick skin types I-V and moderate-to-severe infraorbital dark circles who applied for treatment at the Dermatology Department in the Cosmetology Unit of Medical Faculty Hospital. Each patient was given manual, pressure-controlled injections of sterile CO2 into the upper and lower eyelids for 7 weeks, with one round of treatment per week. We conducted dermatoclinical and radiological evaluations, including measurements of epidermis–dermis thickness and SWE elastography, musculus orbicularis oculi pars pretarsalis thickness, and cSMI vascular index percentage, as well as SOOF tissue SWE elastography (measured in Kpa). These analyses were performed on both lower eyelids before treatment and at 1 month and 6 months after treatment. Results: After treatment, VAS scores improved significantly. Grayscale ultrasonography showed significant increases in epidermis–dermis and orbicularis oculi thickness at 1 and 6 months (p<0.05). SMI presented a significant increase in vascular index at both follow-ups (p<0.05). SOOF SWE values increased significantly at 1 and 6 months, whereas epidermis–dermis SWE did not. Procedural pain was common, and 25 participants withdrew during the 7-week period due to discomfort. Conclusions: Radiological findings indicated collagen accumulation, increased microvascularity, myocyte proliferation, and enhanced viscoelasticity resulting from carboxytherapy treatment. The continuity of radiological and clinical improvements from the first to sixth months following treatment suggests the enduring benefits of this therapy.
- 17 April 2026
- Published by MDPI AG in Preprints.org
Open AccessBeyond Aesthetics: Imaging-Based Evaluation of Carboxytherapy in Periorbital Hyperpigmentation
Background: In this study, we radiologically assessed potential increases in microvascularity, the extracellular matrix, collagen deposition, and tissue viscoelasticity following carboxytherapy for periorbital hyperpigmentation (POH). We also analyzed the correlation between radiological changes and clinical outcomes and explored implications for future outpatient selection, as well as the potential to predict treatment success based on radiological–clinical correlations. Materials and Methods: The present study included 78 patients (76 women and 2 men) aged over 18 years with Fitzpatrick skin types I-V and moderate-to-severe infraorbital dark circles who applied for treatment at the Dermatology Department in the Cosmetology Unit of Medical Faculty Hospital. Each patient was given manual, pressure-controlled injections of sterile CO2 into the upper and lower eyelids for 7 weeks, with one round of treatment per week. We conducted dermatoclinical and radiological evaluations, including measurements of epidermis–dermis thickness and SWE elastography, musculus orbicularis oculi pars pretarsalis thickness, and cSMI vascular index percentage, as well as SOOF tissue SWE elastography (measured in Kpa). These analyses were performed on both lower eyelids before treatment and at 1 month and 6 months after treatment. Results: After treatment, VAS scores improved significantly. Grayscale ultrasonography showed significant increases in epidermis–dermis and orbicularis oculi thickness at 1 and 6 months (p<0.05). SMI presented a significant increase in vascular index at both follow-ups (p<0.05). SOOF SWE values increased significantly at 1 and 6 months, whereas epidermis–dermis SWE did not. Procedural pain was common, and 25 participants withdrew during the 7-week period due to discomfort. Conclusions: Radiological findings indicated collagen accumulation, increased microvascularity, myocyte proliferation, and enhanced viscoelasticity resulting from carboxytherapy treatment. The continuity of radiological and clinical improvements from the first to sixth months following treatment suggests the enduring benefits of this therapy.
- 11 March 2024
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 11 (1) , 52-54
Management of a Major Complication of Robotic Partial Nephrectomy
- 11 March 2024
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 11 (1) , 52-54
Management of a Major Complication of Robotic Partial Nephrectomy
- 4 August 2023
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 27 (1)
Abdominal aortic aneurysm healed with calcification in a female patient with Behçet's syndrome: A case report with a 2‐decade follow‐up
Abdominal aortic aneurysms (AAA) are rare in Behçet syndrome (BS) but may result in life‐threatening complications. AAA are generally treated with surgical intervention following aggressive immunosuppressive therapy. Healing with wall calcification and mural thrombus for AAA is scarcely reported in the literature. Herein, we present a female patient who developed a large saccular aneurysm in the infra‐renal abdominal aorta 6 months after the diagnosis. Endovascular intervention was not found to be possible because of the dimensions of the aneurysm and the patient did not consent for open surgery. Therefore, she received only immunosuppressive treatment. By the second year of follow‐up, we detected reduction in the size of AAA, along with circumferential wall calcification and mural thrombus. The patient was followed‐up for 20 years without rupture and currently doing well. This case demonstrates that calcified large saccular AAA might not necessitate surgical intervention and be followed‐up for many years without any complication.
- 4 August 2023
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 27 (1)
Abdominal aortic aneurysm healed with calcification in a female patient with Behçet's syndrome: A case report with a 2‐decade follow‐up
Abdominal aortic aneurysms (AAA) are rare in Behçet syndrome (BS) but may result in life‐threatening complications. AAA are generally treated with surgical intervention following aggressive immunosuppressive therapy. Healing with wall calcification and mural thrombus for AAA is scarcely reported in the literature. Herein, we present a female patient who developed a large saccular aneurysm in the infra‐renal abdominal aorta 6 months after the diagnosis. Endovascular intervention was not found to be possible because of the dimensions of the aneurysm and the patient did not consent for open surgery. Therefore, she received only immunosuppressive treatment. By the second year of follow‐up, we detected reduction in the size of AAA, along with circumferential wall calcification and mural thrombus. The patient was followed‐up for 20 years without rupture and currently doing well. This case demonstrates that calcified large saccular AAA might not necessitate surgical intervention and be followed‐up for many years without any complication.
- 22 January 2020
- Published by Hindawi Limited in Andrologia
- Vol. 52 (3) , e13510
A case of proximal partial priapism successfully treated with autologous clot embolisation
Partial priapism is a rare disorder in literature and generally described as a contusion or thrombosis of the cavernous body of the penis secondary to blunt trauma. Because of the rarity of disease, there is not much information about the treatment. Conservative management with nonsteroidal anti‐inflammatory drug is often applied treatment. Here, we presented a proximal partial priapism treated successfully with autologous clot embolisation secondary to pelvic trauma.
- 22 January 2020
- Published by Hindawi Limited in Andrologia
- Vol. 52 (3) , e13510
A case of proximal partial priapism successfully treated with autologous clot embolisation
Partial priapism is a rare disorder in literature and generally described as a contusion or thrombosis of the cavernous body of the penis secondary to blunt trauma. Because of the rarity of disease, there is not much information about the treatment. Conservative management with nonsteroidal anti‐inflammatory drug is often applied treatment. Here, we presented a proximal partial priapism treated successfully with autologous clot embolisation secondary to pelvic trauma.
- 1 September 2019
- Published by Elsevier in Clinical Imaging
- Vol. 57, 124-130
Prognostic value of ADC measurements in predicting overall survival in patients undergoing 90Y radioembolization for colorectal cancer liver metastases
- 1 September 2019
- Published by Elsevier in Clinical Imaging
- Vol. 57, 124-130
Prognostic value of ADC measurements in predicting overall survival in patients undergoing 90Y radioembolization for colorectal cancer liver metastases
- 1 May 2019
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 40 (5) , 461-468
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma
Yttrium-90 (90Y) microsphere therapy has been increasingly used to treat hepatocellular carcinoma (HCC) and liver metastasis of colorectal cancer (mCRC). This study aims to compare two different criterias used for therapy response evaluation following 90Y therapy within the same group of patients. A total of 21 patients with HCC and 19 patients with mCRC were included in this study, with 36 and 42 liver lesions, respectively. The lesions were evaluated before and after therapy by CT or MRI and fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT. Several metabolic parameters were analyzed including maximum and mean standardized uptake values, peak standardized uptake value, metabolic tumor volume (MTV), and total lesion glycolysis. Tumor volume was determined using CT or MRI images for all lesions, and the applied activity was estimated to deliver 120±20 Gy for the treated lobe. Six weeks after 90Y microsphere therapy, 18F-FDG PET/CT scan was performed to evaluate tumor response using PERCIST and RECIST criteria. Overall survival was calculated using Kaplan–Meier method. A total of 78 liver lesions were treated without any major complication. The mean tumor volumes of HCC lesions calculated by CT or MRI before and after therapy were 84.38 and 86.62 cm3, respectively. The average MTV of these lesions on PET images was calculated as 68.142 mm3 before therapy and 56.945 mm3 after treatment. In patients with mCRC, the mean tumor volume was 52.32 cm3 before therapy and 54.52 cm3 after therapy. The average MTV was calculated as 41.720 mm3 before and 44.967 mm3 after therapy for the same patient group. Response Evaluation Criteria In Solid Tumors (RECIST) and PET Response Criteria In Solid Tumors incompatibility was seen in seven of 36 lesions in HCC-diagnosed patients and seven of 42 lesions in patients with mCRC. The mean overall survival was calculated as 13.09 months in patients with HCC and 10.6 months in patients with mCRC. 90Y therapy response can be evaluated by both RECIST and European Organization for Research and Treatment of Cancer criteria. However, RECIST and European Organization for Research and Treatment of Cancer incompatibility can be seen. The anatomic methods for evaluating HCC response is relatively more accurate, whereas the metabolic parameters guided by PET/CT scan showed greater importance in response to evaluation of liver mCRC.
- 1 May 2019
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 40 (5) , 461-468
Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma
Yttrium-90 (90Y) microsphere therapy has been increasingly used to treat hepatocellular carcinoma (HCC) and liver metastasis of colorectal cancer (mCRC). This study aims to compare two different criterias used for therapy response evaluation following 90Y therapy within the same group of patients. A total of 21 patients with HCC and 19 patients with mCRC were included in this study, with 36 and 42 liver lesions, respectively. The lesions were evaluated before and after therapy by CT or MRI and fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT. Several metabolic parameters were analyzed including maximum and mean standardized uptake values, peak standardized uptake value, metabolic tumor volume (MTV), and total lesion glycolysis. Tumor volume was determined using CT or MRI images for all lesions, and the applied activity was estimated to deliver 120±20 Gy for the treated lobe. Six weeks after 90Y microsphere therapy, 18F-FDG PET/CT scan was performed to evaluate tumor response using PERCIST and RECIST criteria. Overall survival was calculated using Kaplan–Meier method. A total of 78 liver lesions were treated without any major complication. The mean tumor volumes of HCC lesions calculated by CT or MRI before and after therapy were 84.38 and 86.62 cm3, respectively. The average MTV of these lesions on PET images was calculated as 68.142 mm3 before therapy and 56.945 mm3 after treatment. In patients with mCRC, the mean tumor volume was 52.32 cm3 before therapy and 54.52 cm3 after therapy. The average MTV was calculated as 41.720 mm3 before and 44.967 mm3 after therapy for the same patient group. Response Evaluation Criteria In Solid Tumors (RECIST) and PET Response Criteria In Solid Tumors incompatibility was seen in seven of 36 lesions in HCC-diagnosed patients and seven of 42 lesions in patients with mCRC. The mean overall survival was calculated as 13.09 months in patients with HCC and 10.6 months in patients with mCRC. 90Y therapy response can be evaluated by both RECIST and European Organization for Research and Treatment of Cancer criteria. However, RECIST and European Organization for Research and Treatment of Cancer incompatibility can be seen. The anatomic methods for evaluating HCC response is relatively more accurate, whereas the metabolic parameters guided by PET/CT scan showed greater importance in response to evaluation of liver mCRC.
- Open Access
- 8 March 2019
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 65 (1) , 40-50
The effect of shear-wave elastography on functional results and muscle stiffness in patients undergoing non-selective and selective open kinetic chain exercises
This study aims to assess the effect of shear-wave elastography (SWE) on vastus medialis obliquus (VMO) and vastus lateralis (VL) muscle performances and functional outcomes of patients with patellofemoral pain syndrome (PFPS) undergoing non-selective open kinetic chain exercises (NSOKCE) and selective open kinetic chain exercises (SOKCE). This randomized-controlled clinical trial included a total of 40 patients with PFPS (20 males, 20 females; mean age 46.5±9.8 years, range, 27 to 65 years) and 40 healthy controls (20 males, 20 females; mean age 36.3±11.2 years, range, 23 to 71) between February 2013 and August 2014. The participants in each group were randomized into subgroups according to NSOKCE or SOKCE for six weeks. The VMO and VL muscles were assessed with the SWE, thigh circumferences were measured, and the Visual Analog Scale (VAS) and Lysholm Knee Scale (LKS) scores were obtained. The OKCE alleviated pain, improved LKS scores, and increased the thigh circumference in PFPS patients. While the healthy controls were able to increase the resting muscle tone of their VMO, the patients with PFPS failed in their both knees. Similarly, resting as well as contracted VMO and VL muscles' functions were improved significantly by both NSOKCE and SOKCE in the healthy controls. The NSOKCE improved the VAS scores in the PFPS group. The increase in the muscle mass of the affected sides of PFPS patients were more evident with NSOKCE. Our study results show that NSOKCE planning can be preferred over SOKCE, thanks to its contribution to pain improvement and increase in the thigh circumference in the conservative treatment of PFPS.
- 8 March 2019
- Published by Galenos Yayinevi in Turkish Journal of Physical Medicine and Rehabilitation
- Vol. 65 (1) , 40-50
Open AccessThe effect of shear-wave elastography on functional results and muscle stiffness in patients undergoing non-selective and selective open kinetic chain exercises
This study aims to assess the effect of shear-wave elastography (SWE) on vastus medialis obliquus (VMO) and vastus lateralis (VL) muscle performances and functional outcomes of patients with patellofemoral pain syndrome (PFPS) undergoing non-selective open kinetic chain exercises (NSOKCE) and selective open kinetic chain exercises (SOKCE). This randomized-controlled clinical trial included a total of 40 patients with PFPS (20 males, 20 females; mean age 46.5±9.8 years, range, 27 to 65 years) and 40 healthy controls (20 males, 20 females; mean age 36.3±11.2 years, range, 23 to 71) between February 2013 and August 2014. The participants in each group were randomized into subgroups according to NSOKCE or SOKCE for six weeks. The VMO and VL muscles were assessed with the SWE, thigh circumferences were measured, and the Visual Analog Scale (VAS) and Lysholm Knee Scale (LKS) scores were obtained. The OKCE alleviated pain, improved LKS scores, and increased the thigh circumference in PFPS patients. While the healthy controls were able to increase the resting muscle tone of their VMO, the patients with PFPS failed in their both knees. Similarly, resting as well as contracted VMO and VL muscles' functions were improved significantly by both NSOKCE and SOKCE in the healthy controls. The NSOKCE improved the VAS scores in the PFPS group. The increase in the muscle mass of the affected sides of PFPS patients were more evident with NSOKCE. Our study results show that NSOKCE planning can be preferred over SOKCE, thanks to its contribution to pain improvement and increase in the thigh circumference in the conservative treatment of PFPS.
- 1 September 2018
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 99 (9) , 579-580
Preoperative arterial embolization of endobronchial glomus tumor before endoscopic removal
- 1 September 2018
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 99 (9) , 579-580
Preoperative arterial embolization of endobronchial glomus tumor before endoscopic removal